REG - FIL Limited Medtronic, Inc. - Form 8.3 - COVIDIEN PLC <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 0388VFIL Limited22 October 2014FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE1. KEY INFORMATION
Name of person dealing (Note 1)
FMR LLC and/or one or more of its direct or indirect subsidiaries
And
FIL Limited and/or one or more of its direct and indirect subsidiaries
Company dealt in
COVIDIEN PLC
Class of relevant security to which the dealings being disclosed relate(Note 2)
Ordinary shares
Date of dealing
21-October-14
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in(Note 3)
Long
Short
Number (%)
Number (%)
(1) Relevant securities
18,365,593 4.06
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
18,365,593 4.06
b) Interests and short positions in relevant securities of the company, other than the
class dealt in(Note 3)
Class of relevant security:
Long
Short
Number (%)
Number (%)
(91) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
3. DEALINGS(Note 4)
(91) Purchases and sales
Purchase/sale
Number of securities
Price per unit
Buy
71,481
89.5700 USD/ Share
Buy
26,119
88.6346 USD/ Share
Buy
1,400
89.3786 USD/ Share
Buy
7,573
89.4375 USD/ Share
Buy
623
89.4727 USD/ Share
Buy
300
89.4500 USD/ Share
Buy
4
89.3900 USD/ Share
Buy
5
87.9000 USD/ Share
Buy
5,400
89.4972 USD/ Share
Buy
100
89.4800 USD/ Share
Sale
71,481
89.5700 USD/ Share
Sale
16,255
89.6005 USD/ Share
Sale
35,264
89.6124 USD/ Share
Buy
7
89.2500 USD/ Share
Buy
64
83.97 USD/ Share
Sale
167
83.79 USD/ Share
Sale
21
84.71 USD/ Share
Sale
59
84.45 USD/ Share
Buy
10
84.48 USD/ Share
Buy
85
84.20 USD/ Share
Sale
113
83.98 USD/ Share
Sale
4
83.99 USD/ Share
Buy
3
83.96 USD/ Share
Sale
3
83.96 USD/ Share
Buy
9
83.80 USD/ Share
Sale
12
84.30 USD/ Share
Buy
7
84.31 USD/ Share
Sale
7
84.23 USD/ Share
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD
Nature of transaction (Note 6)
Number of securities (Note 7)
Price per unit (Note 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option
Writing, selling, purchasing, varying etc.
Number of securities to which the option relates (Note 7)
Exercise
price
Type, e.g. American, European etc.
Expiry
date
Option money
paid/received per unit (Note 5)
(ii) Exercising
Product name, e.g. call option
Number of securities
Exercise price per unit (Note 5)
(d) Other dealings (including transactions in respect of new securities)(Note 4)
Nature of transaction (Note 8)
Details
Price per unit (if applicable)(Note 5)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached?(Note 9)NO
Date of disclosure
22 October 2014
Contact name
Nevelina Rousseva-Gasnier
Telephone number
+44 (0)1737 837216
If a connected EFM, name of offeree/offeror with which connected
N/A
If a connected EFM, state nature of connection (Note 10)
N/A
This information is provided by RNSThe company news service from the London Stock ExchangeENDISELLFVSILLFFIS
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement